Browse drugs

…he syndromic management guidelines, we estimate that 70%–80% of antibiotics for NG/CT would currently be given to women without these infec…

…o evaluate the efficacy of vascular-targeted pharmacotherapies (statins, phosphodiesterase-4 inhibitors, long-acting bronchodilators). …

…lymyalgia rheumatica or giant cell arteritis after cessation of prednisolone treatment. Criteria for randomisation are an AddiQoL-30 score ≤…

…ing pathway, further validated with the selective GPR35 agonist Zaprinast, confers neuroprotection by shifting microglial polarisation to…

…ntergenic spacer region. The lesions dramatically improved with clarithromycin and ofloxacin, which were continued for a total of 5 months.…

…ion of its training data and exposing underlying brittleness.In Llama-3.3-70B and Gemini-2.5-Flash, reasoning amplified model vulnerability t…

… tumour necrosis factor inhibitors (TNFi-IR) on the efficacy of certolizumab pegol (CZP) in patients with rheumatoid arthritis (RA) through a post…

…iven the growing burden of AF and limited healthcare resources, Sphere-9 presents a valuable option for improving patient outcomes while…

…low number of AEs supports a favourable risk-benefit profile of faricimab in a real-world setting.…

…adone and benzodiazepines, prompting the sequential addition of flumazenil, which led to full neurological recovery. This case highlights …

…larithromycin for 1 month, followed by maintenance therapy with clarithromycin and clofazimine (CFZ). One year after starting CFZ, she develop…

…gical feature. This case report demonstrates the application of 18F-DPA-714 positron emission tomography (PET)/MRI, a second-generation tra…